Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA Margin 2010-2025 | GILD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Gilead Sciences (GILD) over the last 10 years. The current EBITDA margin for Gilead Sciences as of March 31, 2025 is .
  
Gilead Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $28.74B $10.99B 38.26%
2024-12-31 $28.75B $4.43B 15.40%
2024-09-30 $28.30B $3.59B 12.67%
2024-06-30 $27.81B $5.31B 19.11%
2024-03-31 $27.45B $4.32B 15.74%
2023-12-31 $27.12B $10.30B 37.98%
2023-09-30 $27.39B $10.79B 39.40%
2023-06-30 $27.38B $10.85B 39.61%
2023-03-31 $27.04B $11.06B 40.88%
2022-12-31 $27.28B $9.43B 34.58%
2022-09-30 $27.14B $8.11B 29.90%
2022-06-30 $27.52B $9.12B 33.13%
2022-03-31 $27.47B $9.33B 33.95%
2021-12-31 $27.31B $11.97B 43.83%
2021-09-30 $27.48B $13.57B 49.38%
2021-06-30 $26.64B $11.56B 43.40%
2021-03-31 $25.56B $6.16B 24.11%
2020-12-31 $24.69B $5.55B 22.48%
2020-09-30 $23.15B $3.92B 16.92%
2020-06-30 $22.17B $0.43B 1.96%
2020-03-31 $22.72B $5.85B 25.74%
2019-12-31 $22.45B $5.69B 25.35%
2019-09-30 $22.37B $5.75B 25.71%
2019-06-30 $22.36B $9.86B 44.09%
2019-03-31 $22.32B $9.72B 43.53%
2018-12-31 $22.13B $9.63B 43.52%
2018-09-30 $22.28B $10.82B 48.54%
2018-06-30 $23.20B $11.94B 51.49%
2018-03-31 $24.69B $13.86B 56.13%
2017-12-31 $26.11B $15.41B 59.03%
2017-09-30 $27.48B $17.06B 62.08%
2017-06-30 $28.47B $17.65B 62.00%
2017-03-31 $29.10B $17.92B 61.57%
2016-12-31 $30.39B $18.79B 61.83%
2016-09-30 $31.58B $20.35B 64.46%
2016-06-30 $32.37B $21.52B 66.47%
2016-03-31 $32.84B $22.59B 68.77%
2015-12-31 $32.64B $23.29B 71.36%
2015-09-30 $31.45B $22.00B 69.95%
2015-06-30 $29.19B $19.88B 68.10%
2015-03-31 $27.49B $18.67B 67.93%
2014-12-31 $24.89B $16.32B 65.55%
2014-09-30 $20.70B $13.04B 62.98%
2014-06-30 $17.44B $10.50B 60.24%
2014-03-31 $13.67B $7.05B 51.60%
2013-12-31 $11.20B $4.87B 43.47%
2013-09-30 $10.67B $4.72B 44.27%
2013-06-30 $10.31B $4.62B 44.81%
2013-03-31 $9.95B $4.52B 45.44%
2012-12-31 $9.70B $4.29B 44.20%
2012-09-30 $9.31B $4.05B 43.47%
2012-06-30 $9.01B $4.01B 44.52%
2012-03-31 $8.74B $3.98B 45.49%
2011-12-31 $8.39B $4.09B 48.81%
2011-09-30 $8.18B $4.06B 49.60%
2011-06-30 $8.00B $4.03B 50.38%
2011-03-31 $7.79B $3.99B 51.21%
2010-12-31 $7.95B $4.23B 53.17%
2010-09-30 $7.98B $4.45B 55.74%
2010-06-30 $7.85B $4.35B 55.48%
2010-03-31 $7.57B $4.12B 54.40%
2009-12-31 $7.01B $3.74B 53.38%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $142.753B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $237.532B 17.33
Amgen (AMGN) United States $162.048B 14.52
Vertex Pharmaceuticals (VRTX) United States $120.479B 0.00
Bristol Myers Squibb (BMY) United States $93.573B 6.26
CSL (CSLLY) Australia $84.456B 0.00
GSK (GSK) United Kingdom $79.559B 9.23
Regeneron Pharmaceuticals (REGN) United States $59.876B 14.53
Alnylam Pharmaceuticals (ALNY) United States $44.306B 0.00
Argenex SE (ARGX) Netherlands $36.652B 99.82
BioNTech SE (BNTX) Germany $26.455B 0.00
Royalty Pharma (RPRX) United States $20.870B 8.82
Insmed (INSM) United States $19.954B 0.00
Biogen (BIIB) United States $18.556B 8.01
Illumina (ILMN) United States $16.884B 32.03
Incyte (INCY) United States $15.011B 19.29
Genmab (GNMSF) Denmark $14.683B 15.02
Genmab (GMAB) Denmark $14.287B 16.02
Moderna (MRNA) United States $12.434B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.278B 18.32
QIAGEN (QGEN) Netherlands $11.241B 21.87
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.199B 0.00
Exelixis (EXEL) United States $9.921B 17.89
Bio-Techne Corp (TECH) United States $9.047B 33.75
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.951B 0.00
Exact Sciences (EXAS) United States $8.828B 0.00
Roivant Sciences (ROIV) United Kingdom $7.750B 0.00
Legend Biotech (LEGN) United States $7.426B 0.00
Halozyme Therapeutics (HALO) United States $7.403B 14.17
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.135B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.027B 6.90
Repligen (RGEN) United States $6.902B 75.37
Revolution Medicines (RVMD) United States $6.895B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Anbio Biotechnology (NNNN) Germany $6.043B 0.00
TG Therapeutics (TGTX) United States $5.758B 151.12
Nuvalent (NUVL) United States $5.712B 0.00
Guardant Health (GH) United States $5.599B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.386B 0.00
Axsome Therapeutics (AXSM) United States $4.986B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.981B 0.00
Alkermes (ALKS) Ireland $4.611B 12.81
Merus (MRUS) Netherlands $4.579B 0.00
Telix Pharmaceuticals (TLX) Australia $4.568B 0.00
Abivax SA (ABVX) France $4.496B 0.00
Vaxcyte (PCVX) United States $4.492B 0.00
Avidity Biosciences (RNA) United States $4.445B 0.00
ADMA Biologics Inc (ADMA) United States $4.438B 33.20
Krystal Biotech (KRYS) United States $4.428B 34.12
Cytokinetics (CYTK) United States $4.321B 0.00
Zai Lab (ZLAB) China $4.284B 0.00
PTC Therapeutics (PTCT) United States $4.037B 7.03
Arcellx (ACLX) United States $3.942B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.938B 34.60
Zealand Pharma (ZLDPF) Denmark $3.878B 0.00
Akero Therapeutics (AKRO) United States $3.804B 0.00
Viking Therapeutics (VKTX) United States $3.791B 0.00
Metsera (MTSR) United States $3.717B 0.00
Scholar Rock Holding (SRRK) United States $3.592B 0.00
Protagonist Therapeutics (PTGX) United States $3.385B 72.83
Ascentage Pharma Group - (AAPG) China $3.272B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.230B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.194B 0.00
Kymera Therapeutics (KYMR) United States $2.870B 0.00
Immunovant (IMVT) United States $2.843B 0.00
Bavarian Nordic (BVNRY) Denmark $2.815B 14.88
Alvotech (ALVO) Luxembourg $2.798B 16.00
Ligand Pharmaceuticals (LGND) United States $2.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.532B 0.00
Apellis Pharmaceuticals (APLS) United States $2.388B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.362B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.361B 0.00
ImmunityBio (IBRX) United States $2.260B 0.00
IDEAYA Biosciences (IDYA) United States $2.220B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.194B 751.50
Agios Pharmaceuticals (AGIO) United States $2.174B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.169B 0.00
Twist Bioscience (TWST) United States $2.081B 0.00
Belite Bio (BLTE) United States $2.063B 0.00
Disc Medicine (IRON) United States $2.056B 0.00
CG Oncology (CGON) United States $2.051B 0.00
Vericel (VCEL) United States $2.047B 1355.33
Harmony Biosciences Holdings (HRMY) United States $2.037B 13.54
Beam Therapeutics (BEAM) United States $2.026B 0.00
Mesoblast (MESO) Australia $1.998B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Amicus Therapeutics (FOLD) United States $1.888B 204.33
Arcutis Biotherapeutics (ARQT) United States $1.738B 0.00
Apogee Therapeutics (APGE) United States $1.732B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.683B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.681B 0.00
Certara (CERT) United States $1.660B 31.00
Sarepta Therapeutics (SRPT) United States $1.646B 0.00
Liquidia Technologies (LQDA) United States $1.634B 0.00
Biohaven (BHVN) United States $1.593B 0.00
Adaptive Biotechnologies (ADPT) United States $1.586B 0.00
Celcuity (CELC) United States $1.568B 0.00
Celldex Therapeutics (CLDX) United States $1.514B 0.00
Edgewise Therapeutics (EWTX) United States $1.497B 0.00
Viridian Therapeutics (VRDN) United States $1.452B 0.00
Janux Therapeutics (JANX) United States $1.434B 0.00
89BIO (ETNB) United States $1.391B 0.00
ANI Pharmaceuticals (ANIP) United States $1.387B 14.29
Travere Therapeutics (TVTX) United States $1.375B 0.00
Jyong Biotech (MENS) Taiwan $1.365B 0.00
AbCellera Biologics (ABCL) Canada $1.364B 0.00
Vera Therapeutics (VERA) United States $1.345B 0.00
Dynavax Technologies (DVAX) United States $1.341B 79.79
Cogent Biosciences (COGT) United States $1.313B 0.00
Intellia Therapeutics (NTLA) United States $1.277B 0.00
WAVE Life Sciences (WVE) Singapore $1.269B 0.00
Cidara Therapeutics (CDTX) United States $1.246B 0.00
NovoCure (NVCR) Jersey $1.226B 0.00
CureVac (CVAC) Germany $1.216B 5.89
GRAIL (GRAL) United States $1.215B 0.00
MannKind (MNKD) United States $1.176B 24.19
Praxis Precision Medicines (PRAX) United States $1.153B 0.00
Novavax (NVAX) United States $1.110B 2.58
Spyre Therapeutics (SYRE) United States $1.042B 0.00
Pharvaris (PHVS) Netherlands $1.035B 0.00
Structure Therapeutics (GPCR) United States $1.022B 0.00
Pacira BioSciences (PCRX) United States $1.008B 9.59
Arcus Biosciences (RCUS) United States $0.999B 0.00
Sana Biotechnology (SANA) United States $0.983B 0.00
MiMedx (MDXG) United States $0.963B 21.73
Anavex Life Sciences (AVXL) United States $0.954B 0.00
Mineralys Therapeutics (MLYS) United States $0.944B 0.00
Immunome (IMNM) United States $0.935B 0.00
Oric Pharmaceuticals (ORIC) United States $0.913B 0.00
Nurix Therapeutics (NRIX) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.902B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Iovance Biotherapeutics (IOVA) United States $0.892B 0.00
Urogen Pharma (URGN) United States $0.888B 0.00
BGM Group (BGM) China $0.877B 0.00
Trevi Therapeutics (TRVI) United States $0.870B 0.00
LENZ Therapeutics (LENZ) United States $0.866B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.860B 0.00
Nuvation Bio (NUVB) United States $0.820B 0.00
Upstream Bio (UPB) United States $0.817B 0.00
Immatics (IMTX) Germany $0.812B 0.00
UniQure (QURE) Netherlands $0.793B 0.00
Sionna Therapeutics (SION) United States $0.783B 0.00
CorMedix Inc (CRMD) United States $0.783B 52.46
Oculis Holding AG (OCS) Switzerland $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.754B 0.00
Niagen Bioscience (NAGE) United States $0.751B 105.89
AnaptysBio (ANAB) United States $0.734B 0.00
GH Research (GHRS) Ireland $0.727B 0.00
Vir Biotechnology (VIR) United States $0.724B 0.00
Stoke Therapeutics (STOK) United States $0.703B 16.29
Geron (GERN) United States $0.701B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.696B 0.00
Pharming Group (PHAR) Netherlands $0.691B 0.00
Tango Therapeutics (TNGX) United States $0.683B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.682B 0.00
Gyre Therapeutics (GYRE) United States $0.682B 181.75
Maze Therapeutics (MAZE) United States $0.679B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.677B 0.00
ArriVent BioPharma (AVBP) United States $0.670B 0.00
Dianthus Therapeutics (DNTH) United States $0.669B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Zenas BioPharma (ZBIO) United States $0.659B 0.00
NeoGenomics (NEO) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.638B 0.00
MeiraGTx Holdings (MGTX) United States $0.634B 0.00
Bicara Therapeutics (BCAX) United States $0.633B 0.00
Arbutus Biopharma (ABUS) United States $0.632B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.608B 0.00
Tyra Biosciences (TYRA) United States $0.592B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.589B 0.00
Keros Therapeutics (KROS) United States $0.588B 0.00
Replimune (REPL) United States $0.587B 0.00
Septerna (SEPN) United States $0.563B 0.00
Fortrea Holdings (FTRE) United States $0.561B 15.50
Arvinas (ARVN) United States $0.553B 0.00
Solid Biosciences (SLDB) United States $0.548B 0.00
Kura Oncology (KURA) United States $0.545B 0.00
Sage Therapeutics (SAGE) United States $0.544B 0.00
Rapport Therapeutics (RAPP) United States $0.541B 0.00
Prime Medicine (PRME) United States $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Rezolute (RZLT) United States $0.523B 0.00
MBX Biosciences (MBX) United States $0.518B 0.00
Terns Pharmaceuticals (TERN) United States $0.516B 0.00
Precigen (PGEN) United States $0.511B 0.00
Cullinan Therapeutics (CGEM) United States $0.482B 0.00
Gossamer Bio (GOSS) United States $0.473B 0.00
Castle Biosciences (CSTL) United States $0.464B 31.53
Cytek Biosciences (CTKB) United States $0.450B 0.00
PureTech Health (PRTC) United States $0.449B 0.00
ATyr Pharma (ATYR) United States $0.440B 0.00
Erasca (ERAS) United States $0.439B 0.00
REGENXBIO (RGNX) United States $0.439B 0.00
Kamada (KMDA) Israel $0.432B 25.93
Compass Therapeutics (CMPX) United States $0.422B 0.00
Tectonic Therapeutic (TECX) United States $0.421B 0.00
Palvella Therapeutics (PVLA) United States $0.414B 0.00
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Kodiak Sciences (KOD) United States $0.385B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Astria Therapeutics (ATXS) United States $0.380B 0.00
Humacyte (HUMA) United States $0.377B 0.00
Myriad Genetics (MYGN) United States $0.373B 0.00
Fulcrum Therapeutics (FULC) United States $0.373B 0.00
Absci (ABSI) United States $0.372B 0.00
Prothena (PRTA) Ireland $0.370B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.369B 0.00
Northwest Biotherapeutics (NWBO) United States $0.352B 0.00
Olema Pharmaceuticals (OLMA) United States $0.349B 0.00
Abeona Therapeutics (ABEO) United States $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.344B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.343B 69.75
Verastem (VSTM) United States $0.342B 0.00
Neumora Therapeutics (NMRA) United States $0.336B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.335B 0.00
Cartesian Therapeutics (RNAC) United States $0.334B 0.00
Inhibrx Biosciences (INBX) United States $0.333B 0.20
Aura Biosciences (AURA) United States $0.331B 0.00
Emergent Biosolutions (EBS) United States $0.329B 0.00
Candel Therapeutics (CADL) United States $0.329B 0.00
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
Ocugen (OCGN) United States $0.312B 0.00
Neurogene (NGNE) United States $0.312B 0.00
Amarin (AMRN) Ireland $0.310B 0.00
Inventiva S.A (IVA) France $0.308B 0.00
XOMA Royalty (XOMA) United States $0.307B 0.00
Foghorn Therapeutics (FHTX) United States $0.304B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.299B 0.00
Benitec Biopharma (BNTC) United States $0.295B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.292B 0.00
Annexon (ANNX) United States $0.284B 0.00
Allogene Therapeutics (ALLO) United States $0.282B 0.00
ScPharmaceuticals (SCPH) United States $0.277B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.277B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.277B 0.00
Vor Biopharma (VOR) $0.276B 0.00
Aardvark Therapeutics (AARD) United States $0.275B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.275B 0.00
Sagimet Biosciences (SGMT) United States $0.273B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.263B 0.00
Monopar Therapeutics (MNPR) United States $0.261B 0.00
Alpha Teknova (TKNO) United States $0.259B 0.00
Prima BioMed (IMMP) Australia $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Entrada Therapeutics (TRDA) United States $0.252B 8.20
Crescent Biopharma (CBIO) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.243B 0.00
Tvardi Therapeutics (TVRD) United States $0.240B 0.00
Bright Minds Biosciences (DRUG) United States $0.238B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Codexis (CDXS) United States $0.231B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.225B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Alumis (ALMS) United States $0.223B 0.00
AC Immune (ACIU) Switzerland $0.219B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Editas Medicine (EDIT) United States $0.211B 0.00
CARGO Therapeutics (CRGX) United States $0.206B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.195B 0.00
BioStem Technologies (BSEM) $0.193B 7.84
Voyager Therapeutics (VYGR) United States $0.191B 0.00
Ventyx Biosciences (VTYX) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.191B 0.00
Caribou Biosciences (CRBU) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.189B 0.00
Semper Paratus Acquisition (TVGN) United States $0.188B 0.00
Rapt Therapeutics (RAPT) United States $0.187B 0.00
CytomX Therapeutics (CTMX) United States $0.187B 4.83
EnGene Holdings (ENGN) Canada $0.179B 0.00
Instil Bio (TIL) United States $0.177B 0.00
Citius Oncology (CTOR) United States $0.169B 0.00
Cardiff Oncology (CRDF) United States $0.166B 0.00
SELLAS Life Sciences (SLS) United States $0.166B 0.00
I-Mab (IMAB) United States $0.165B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.163B 0.00
Kyverna Therapeutics (KYTX) United States $0.163B 0.00
Agenus (AGEN) United States $0.162B 0.00
Black Diamond Therapeutics (BDTX) United States $0.160B 47.00
Alector (ALEC) United States $0.160B 0.00
Elicio Therapeutics (ELTX) United States $0.159B 0.00
BioAge Labs (BIOA) United States $0.158B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.157B 4.10
Contineum Therapeutics (CTNM) United States $0.155B 0.00
Nkarta (NKTX) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
C4 Therapeutics (CCCC) United States $0.153B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Actuate Therapeutics (ACTU) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.149B 0.00
Cellectis S.A (CLLS) France $0.148B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
IO Biotech (IOBT) Denmark $0.140B 0.00
Genelux (GNLX) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Immuneering (IMRX) United States $0.131B 0.00
23andMe Holding (MEHCQ) United States $0.129B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Seer (SEER) United States $0.128B 0.00
Sangamo Therapeutics (SGMO) United States $0.127B 0.00
Seres Therapeutics (MCRB) United States $0.126B 0.00
BioHarvest Sciences (BHST) Canada $0.122B 0.00
Spero Therapeutics (SPRO) United States $0.122B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.120B 0.00
Tenaya Therapeutics (TNYA) United States $0.119B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.118B 0.00
Connect Biopharma Holdings (CNTB) United States $0.117B 0.00
Anika Therapeutics (ANIK) United States $0.116B 0.00
TuHURA Biosciences (HURA) United States $0.113B 0.00
Coherus Oncology (CHRS) United States $0.112B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.105B 0.00
Climb Bio (CLYM) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.099B 0.00
Zura Bio (ZURA) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Adagene (ADAG) China $0.095B 0.00
OKYO Pharma (OKYO) $0.094B 0.00
Pliant Therapeutics (PLRX) United States $0.093B 0.00
Immunic (IMUX) United States $0.092B 0.00
Entera Bio (ENTX) Israel $0.092B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Scilex Holding (SCLX) United States $0.090B 0.00
Quince Therapeutics (QNCX) United States $0.088B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.088B 0.00
XBiotech (XBIT) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.086B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
Whitehawk Therapeutics (WHWK) United States $0.084B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.082B 0.00
Elutia (ELUT) United States $0.081B 0.00
Cabaletta Bio (CABA) United States $0.079B 0.00
Celularity (CELU) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Artiva Biotherapeutics (ARTV) United States $0.073B 0.00
Atara Biotherapeutics (ATRA) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Oncobiologics (OTLK) United States $0.069B 0.00
Forte Biosciences (FBRX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.066B 0.00
MiNK Therapeutics (INKT) United States $0.066B 0.00
Opus Genetics (IRD) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.065B 0.00
INmune Bio (INMB) United States $0.063B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Cue Biopharma (CUE) United States $0.061B 0.00
Applied Therapeutics (APLT) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.058B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Earth Science Tech (ETST) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Adlai Nortye (ANL) Cayman Islands $0.052B 0.00
CalciMedica (CALC) United States $0.051B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
PDS Biotechnology (PDSB) United States $0.050B 0.00
Adverum Biotechnologies (ADVM) United States $0.050B 0.00
ABVC BioPharma (ABVC) United States $0.049B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Renovaro (RENB) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
KALA BIO (KALA) United States $0.046B 0.00
Alterity Therapeutics - (ATHE) Australia $0.046B 0.00
PepGen (PEPG) United States $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
RenovoRx (RNXT) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Exicure (XCUR) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Cognition Therapeutics (CGTX) United States $0.039B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.038B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Ovid Therapeutics (OVID) United States $0.036B 0.00
Clearside Biomedical (CLSD) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Medicus Pharma (MDCX) United States $0.034B 0.00
Mersana Therapeutics (MRSN) United States $0.034B 0.00
CAMP4 Therapeutics (CAMP) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
ALX Oncology Holdings (ALXO) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.030B 0.00
Clene (CLNN) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.021B 0.00
180 Life Sciences (ATNF) United States $0.021B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Rallybio (RLYB) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.020B 0.00
Passage Bio (PASG) United States $0.019B 0.00
Abpro Holdings (ABP) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Curis (CRIS) United States $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
MetaVia (MTVA) United States $0.012B 0.00
IBio (IBIO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Advanced Biomed (ADVB) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Synaptogenix (TAOX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
LakeShore Biopharma (LSB) China $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Apollomics (APLM) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00